| Line Item | 2023-10-31 | Y/Y |
|---|---|---|
| Revenue | $288K | -98.0% |
| Cost of Revenue | $135K | -98.8% |
| Gross Profit | $30.9M | +70.3% |
| R&D Expense | $18.7M | — |
| SG&A Expense | $17.6M | +309.0% |
| Operating Income | -$5.5M | -139.8% |
| Income Tax | -$2.1M | -142.5% |
| Net Income | -$3.4M | -138.4% |
| EPS (Basic) | -$0.32 |
| Line Item | 2023-10-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.7M | -2.4% |
| Inventory | $359K | — |
| Current Assets | $11.3M | -53.0% |
| Total Assets | $14.0M | -44.9% |
| Current Liabilities | $4.7M | -67.3% |
| Total Liabilities | $5.3M | -64.3% |
| Stockholders' Equity | $8.7M | -17.8% |
| Line Item | 2023-10-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$170K | -103.7% |
| Investing Cash Flow | -$1.6M | -616.4% |
| Financing Cash Flow | $1.9M | — |
| -138.1% |
| EPS (Diluted) | -$0.17 | -139.5% |